The new COVID-19 variant NB.1.8.1, known as Nimbus, is causing concern due to its subtle symptoms and high transmission rate.

Key TakeawaysThe global vaccines market reached USD 87.57 billion in 2024 and is projected to grow to USD 206.78 billion by ...

A new multinational study analyzing data from over 230 million people across 20 global sites highlights the relationship between SARS-CoV-2 infection, certain COVID-19 vaccines, and Guillain ...

Maharashtra recorded four new Covid-related fatalities, bringing the state's death toll to 25 since May. According to state health officials, the deceased were aged between 35 and 85, and all had ...

Key TakeawaysThe global vaccines market reached USD 87.57 billion in 2024 and is projected to grow to USD 206.78 billion by 2035, representing a robust CAGR of 9.80%.Increasing prevalence of ...

New Delhi, Jun 23 (PTI) India's biotechnology sector has expanded rapidly in the past decade, with its bioeconomy growing ...

Preclinical Studies Demonstrate Durable Protection Against SARS-CoV-2 Variants, Including Omicron XBB.1.5, Driven by T-Cell Responses  ATLANTA, GA - June 9, 2025 (NEWMEDIAWIRE) - GeoVax Labs, Inc.

GEO-CM04S1 Demonstrates Superior T Cell Responses Compared to mRNA Vaccine in Phase 2 Trial Among Immunocompromised Patients ...

MVA Vaccine Design for Products Used Against Endemic and Emerging Infectious Diseases. ATLANTA, GA - June 25, 2025 (NEWMEDIAWIRE) - GeoVax La ...

The same tools that companies use to sell products can be used to encourage people to get vaccinated, get a colonoscopy or ...

India's biotechnology sector has grown fivefold in a decade, reaching USD 165.7 billion in 2024, driven by innovation and ...